Albocycline
Albocycline (Ingramycin) is a macrolide antibiotic, which exhibits antibacterial activities against methicillin-resistant Staphylococcus aureus (MRSA), Vancomycin (HY-B0671) -intermediate (VISA), and Vancomycin (HY-B0671) -resistant S. aureus (VRSA) strains with MICs ranging from 0.5 to 1.0 μg/mL. Albocycline exhibits no toxicity to human cells at concentration of ≤64 μg/mL[1].
Product Specifications
CAS Number
[25129-91-3]
Product Name Alternative
Ingramycin
UNSPSC
12352005
Hazard Statement
H301
Target
Antibiotic; Bacterial
Type
Natural Products
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/albocycline.html
Smiles
O=C1O[C@H](C)[C@@H](C)CC/C=C(C)/[C@@H](OC)/C=C/[C@@](C)(O)/C=C/1
Molecular Formula
C18H28O4
Molecular Weight
308.41
Precautions
P264-P270-P330-P405-P501
References & Citations
[1]Daher SS, et al., Synthesis and biological evaluation of semi-synthetic albocycline analogs. Bioorg Med Chem Lett. 2020 Nov 1;30 (21) :127509.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
Macrolide
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Metadherin (MTDH, 3D3, 3D3/LYRIC, AEG1, AEG-1, Astrocyte elevated gene-1 protein, LYRIC, LYRIC/3D3, Lysine-rich CEACAM1 co-isolated protein, Metastasis adhesion protein, Protein LYRIC) (HRP) discontinued
Lentiviral human TP53I3 sgRNA gene knockout kit - Lentiviral human TP53I3 sgRNA gene knockout kit (plasmid)
